AwesomeAvani

MGNX a biotech company gets new "Outperform" LONG

Long
AwesomeAvani Updated   
BATS:MGNX   MacroGenics, Inc.
MGNX as a biotech company makes antibodies against certain cancers. The antibody is tagged to

chemotherapy molecules and then heads off looking for cancer cells to which it has a strong

affinity. So much for the science. MGNX just got upgraded and the new target is $ 16.00 about

25% upside. Biotech and healthcare are projected hot sectors this year.

On the 15 minute chart price jumped about 12% in the past week and bounced down toward

the anchored mean VWAP and is well situated for a long entry. the dual TF RSI indicator

shows both lines crossing the 50 level in early bullish momentum off the bounce.

It is continually hitting new past year highs at a great trend angle and is on pace to hit 400% for

an annual return. There is no option play here as the volume is minimal and liquidity is absent.

The all-time high is about $32 so there is plenty of room above the analyst's target over the long

term. Price has moved 12X the S & P YTD certainly a sign of relative strength.
Trade active:
MGNX up 10% for the week overall. Holding full position. This is expected to be

a long-duration swing trade. When the position is up 10% I will close 20% of the

position.
Trade active:
Trade is up 15% - 20% of the position is closed trailing stop loss of 5% on the remaining 80% now a risk-free trade.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.